# FDA Inspection 1245264 - Exquisite Corporation - August 01, 2024

Source: https://www.keypedia.com/records/fda_inspections/exquisite-corporation/95345e92-b26f-4201-a42b-a6dc10f58cab
Source feed: FDA_Inspections

> FDA Inspection 1245264 for Exquisite Corporation on August 01, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245264
- Company Name: Exquisite Corporation
- Inspection Date: 2024-08-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1205627 - 2023-04-26](https://www.keypedia.com/records/fda_inspections/exquisite-corporation/a92c52f0-0158-42ec-8881-84dd088a3415)
- [FDA Inspection 815499 - 2013-01-09](https://www.keypedia.com/records/fda_inspections/exquisite-corporation/8cfa743c-0716-4cce-90a0-859f5f1b03c2)

Company: https://www.keypedia.com/companies/exquisite-corporation/cf4dd029-0549-4ddb-b1f4-83e7a2559f7c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c